iShares U.S. Healthcare ETF Rating $72.10 +0.56 (+0.78%) As of 09:40 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest iShares U.S. Healthcare ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IYH Aggregate RatingModerate Buy 2.75Holdings in IYH have an aggregate rating of Moderate Buy based on 630 analyst ratings issued in the past year covering 25 companies (79.5% of the portfolio).IYH Aggregate Price Target$71.54High Prediction$71.54Average Prediction$71.54Low Prediction$71.54Holdings in IYH have an aggregate price target of $71.54 and a range of $71.54 to $71.54 covering 25 companies (79.5% of the portfolio).IYH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IYH Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings14.51%LLYEli Lilly and Company$1,173.90+2.0%Moderate Buy$1,308.39 11.5%304.5507 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision10.27%JNJJohnson & Johnson$274.40+1.9%Moderate Buy$274.13 -0.1%254.4149 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision7.37%ABBVAbbVie$265.11+0.0%Moderate Buy$276.64 4.3%253.8507 of 5 stars5.74%MRKMerck & Co., Inc.$150.75+1.8%Moderate Buy$154.24 2.3%244.1667 of 5 stars5.34%UNHUnitedHealth Group$369.55-0.5%Moderate Buy$456.56 23.5%274.9689 of 5 starsAnalyst Revision3.86%TMOThermo Fisher Scientific$666.53+0.2%Moderate Buy$624.64 -6.3%263.7782 of 5 starsTrending News3.23%AMGNAmgen$408.19+0.5%Hold$383.46 -6.1%303.6037 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision2.96%GILDGilead Sciences$150.90-0.3%Moderate Buy$158.78 5.2%293.4876 of 5 starsTrending NewsAnalyst Revision2.79%ABTAbbott Laboratories$103.69+0.2%Moderate Buy$119.50 15.2%274.8472 of 5 starsDividend Announcement2.48%PFEPfizer$28.60+1.5%Hold$28.39 -0.7%212.725 of 5 starsTrending News2.13%ISRGIntuitive Surgical$398.150.0%Moderate Buy$508.68 27.8%314.3892 of 5 stars2.12%DHRDanaher$222.15+0.3%Moderate Buy$230.23 3.6%243.3579 of 5 starsAnalyst Forecast2.07%VRTXVertex Pharmaceuticals$524.24+1.5%Moderate Buy$573.83 9.5%233.7852 of 5 starsAnalyst Forecast2.02%BMYBristol Myers Squibb$61.33+0.3%Moderate Buy$67.06 9.3%254.7436 of 5 starsAnalyst Forecast1.88%MDTMedtronic$89.61+0.3%Moderate Buy$103.92 16.0%284.9628 of 5 starsTrending News1.53%SYKStryker$272.13-0.5%Moderate Buy$374.42 37.6%234.9492 of 5 starsAnalyst Forecast1.42%ELVElevance Health$398.500.0%Moderate Buy$440.90 10.6%234.1748 of 5 stars1.26%REGNRegeneron Pharmaceuticals$801.90+0.0%Moderate Buy$802.18 0.0%243.7165 of 5 starsAnalyst Forecast1.14%CICigna Group$267.33-0.4%Moderate Buy$337.10 26.1%234.9141 of 5 stars1.02%BSXBoston Scientific$44.66+0.1%Moderate Buy$70.19 57.2%314.714 of 5 starsAnalyst Forecast1.01%HCAHCA Healthcare$439.60+0.7%Moderate Buy$463.70 5.5%243.3759 of 5 starsAnalyst Upgrade0.91%MRNAModerna$185.28+1.7%Hold$76.72 -58.6%241.9884 of 5 starsTrending NewsAnalyst Forecast0.81%BDXBecton, Dickinson and Company$182.63+0.1%Hold$187.67 2.8%173.0682 of 5 stars0.79%NTRANatera$395.95+1.3%Moderate Buy$330.83 -16.4%231.6001 of 5 stars0.79%EWEdwards Lifesciences$87.01+0.2%Moderate Buy$100.27 15.2%234.2577 of 5 starsPositive News This page (NYSEARCA:IYH) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Healthcare ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
